Fig. 6From: Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabineWestern blot analysis of checkpoint factors. Whole cell lysates from UCCs treated with gemcitabine (10 nM) and/or AZD7762 (10 or 20 nM) for 24 or 48 h were assayed for the indicated proteins or their phosphorylation. As loading controls, GAPDH or α-tubulin were stained on each blotBack to article page